Close

People

Ross Elfand is a seasoned antitrust trial lawyer who has served as lead and co-lead counsel in high profile matters on behalf of leading pharmaceutical and technology companies. He regularly represents companies as the lead advocate before competition enforcement agencies, including the Federal Trade Commission, state attorneys general offices, and other agencies around the world.

Ross often serves as co-lead counsel in large-scale, complex, and high-risk matters, including multi-district cartel and monopolization cases in the United States. He is a skilled litigator of claims involving the interplay between intellectual property and antitrust laws in the pharmaceutical industry.

Ross is a trusted legal advisor on antitrust risks associated with product development, contracting, marketing, joint ventures, and patent-related issues. He also advises companies in the technology industry regarding the intersection of global privacy and competition laws.

Full Bio

Credentials

J.D., Brooklyn Law School, Magna Cum Laude

B.A., Emory University

New Jersey

New York

Supreme Court of the United States

U.S. Court of Appeals for the Second Circuit

U.S. District Court for the Eastern District of New York

U.S. District Court for the Southern District of New York

Law Clerk, Magistrate Judge Gabriel W. Gorenstein, U.S. District Court for the Southern District of New York

News

In the News · Source: Law360, New York Law Journal, Competition Policy International, Bloomberg Law, Commercial Dispute Resolution, Global Competition Review and Reuters Daily Docket

October 28, 2024
Antitrust partner Ross Elfand joins the firm’s Business Litigation practice group in New York

View all

Matters

Pharmaceutical Antitrust

Regeneron v. Novartis – Represented Novartis as co-lead counsel in antitrust litigation involving Walker Process monopolization claims relating to a patent covering syringes prefilled with an anti-VEGF drug that treats ophthalmic conditions.

Represented Pfizer as co-lead counsel in ground-breaking antitrust litigation regarding the impact of contracting and rebating practices on biosimilars.

In re Aggrenox Antitrust Litigation – Represented Boehringer lngelheim as co-lead counsel in class action multidistrict litigation arising from alleged delay in generic competition to Aggrenox, due to a claimed “reverse payment” patent settlement and obtained appellate victory in challenge to class action settlements.

See more

Close

Matters

Pharmaceutical Antitrust

Regeneron v. Novartis – Represented Novartis as co-lead counsel in antitrust litigation involving Walker Process monopolization claims relating to a patent covering syringes prefilled with an anti-VEGF drug that treats ophthalmic conditions.

Represented Pfizer as co-lead counsel in ground-breaking antitrust litigation regarding the impact of contracting and rebating practices on biosimilars.

In re Aggrenox Antitrust Litigation – Represented Boehringer lngelheim as co-lead counsel in class action multidistrict litigation arising from alleged delay in generic competition to Aggrenox, due to a claimed “reverse payment” patent settlement and obtained appellate victory in challenge to class action settlements.

In re Loestrin Antitrust Litigation – Represented Warner Chilcott in class action litigation challenging the company’s settlements of patent litigation relating to the oral contraceptive Loestrin.

Cartel

In re Domestic Drywall Antitrust Litigation – Represented CertainTeed Gypsum in the homebuilders' opt-out antitrust litigation alleging price fixing among producers of drywall products.

In re TFT-LCD (Flat Panel) Antitrust Litigation – Represented Toshiba in civil cases involving allegations of price-fixing of LCD panels, including two class actions and numerous opt-out cases. After a six-week trial where the Plaintiff alleged damages of over $2 billion, the jury unanimously found no liability against Toshiba. In an earlier six-week trial, the jury found no recoverable damages against Toshiba where the Plaintiffs alleged class-wide damages of nearly $3 billion.

Defended Toshiba as the lead for the defense group in three separate state antitrust actions filed by state attorneys general in Mississippi, Washington, and Illinois, alleging price­ fixing of LCD panels.

Fair Isaac Corporation v. Equifax, et al. – Represented Experian Information Solutions, Inc. in an action brought by FICO, the dominant provider of consumer credit risk scoring services, against the three major U.S. credit bureaus alleging collusion and trademark violations in the sale of credit scoring services, securing summary judgment on the antitrust claims and a jury verdict on the trademark claims. The jury also found that FICO committed fraud on the U.S. Patent and Trademark Office in procuring registration of the trademark. Secured affirmation of both the antitrust dismissal and the jury's verdict on appeal to the Eighth Circuit Court of Appeals.

Global Investigations

Represented technology companies as global counsel in competition investigations by enforcement agencies in the United States, Europe, India, Argentina, Chile, Mexico, and numerous other jurisdictions.

News

In the News · Source: Law360, New York Law Journal, Competition Policy International, Bloomberg Law, Commercial Dispute Resolution, Global Competition Review and Reuters Daily Docket

October 28, 2024
Antitrust partner Ross Elfand joins the firm’s Business Litigation practice group in New York

View all

Matters

Pharmaceutical Antitrust

Regeneron v. Novartis – Represented Novartis as co-lead counsel in antitrust litigation involving Walker Process monopolization claims relating to a patent covering syringes prefilled with an anti-VEGF drug that treats ophthalmic conditions.

Represented Pfizer as co-lead counsel in ground-breaking antitrust litigation regarding the impact of contracting and rebating practices on biosimilars.

In re Aggrenox Antitrust Litigation – Represented Boehringer lngelheim as co-lead counsel in class action multidistrict litigation arising from alleged delay in generic competition to Aggrenox, due to a claimed “reverse payment” patent settlement and obtained appellate victory in challenge to class action settlements.

See more

Close

Matters

Pharmaceutical Antitrust

Regeneron v. Novartis – Represented Novartis as co-lead counsel in antitrust litigation involving Walker Process monopolization claims relating to a patent covering syringes prefilled with an anti-VEGF drug that treats ophthalmic conditions.

Represented Pfizer as co-lead counsel in ground-breaking antitrust litigation regarding the impact of contracting and rebating practices on biosimilars.

In re Aggrenox Antitrust Litigation – Represented Boehringer lngelheim as co-lead counsel in class action multidistrict litigation arising from alleged delay in generic competition to Aggrenox, due to a claimed “reverse payment” patent settlement and obtained appellate victory in challenge to class action settlements.

In re Loestrin Antitrust Litigation – Represented Warner Chilcott in class action litigation challenging the company’s settlements of patent litigation relating to the oral contraceptive Loestrin.

Cartel

In re Domestic Drywall Antitrust Litigation – Represented CertainTeed Gypsum in the homebuilders' opt-out antitrust litigation alleging price fixing among producers of drywall products.

In re TFT-LCD (Flat Panel) Antitrust Litigation – Represented Toshiba in civil cases involving allegations of price-fixing of LCD panels, including two class actions and numerous opt-out cases. After a six-week trial where the Plaintiff alleged damages of over $2 billion, the jury unanimously found no liability against Toshiba. In an earlier six-week trial, the jury found no recoverable damages against Toshiba where the Plaintiffs alleged class-wide damages of nearly $3 billion.

Defended Toshiba as the lead for the defense group in three separate state antitrust actions filed by state attorneys general in Mississippi, Washington, and Illinois, alleging price­ fixing of LCD panels.

Fair Isaac Corporation v. Equifax, et al. – Represented Experian Information Solutions, Inc. in an action brought by FICO, the dominant provider of consumer credit risk scoring services, against the three major U.S. credit bureaus alleging collusion and trademark violations in the sale of credit scoring services, securing summary judgment on the antitrust claims and a jury verdict on the trademark claims. The jury also found that FICO committed fraud on the U.S. Patent and Trademark Office in procuring registration of the trademark. Secured affirmation of both the antitrust dismissal and the jury's verdict on appeal to the Eighth Circuit Court of Appeals.

Global Investigations

Represented technology companies as global counsel in competition investigations by enforcement agencies in the United States, Europe, India, Argentina, Chile, Mexico, and numerous other jurisdictions.

News

In the News · Source: Law360, New York Law Journal, Competition Policy International, Bloomberg Law, Commercial Dispute Resolution, Global Competition Review and Reuters Daily Docket

October 28, 2024
Antitrust partner Ross Elfand joins the firm’s Business Litigation practice group in New York

View all

Credentials

J.D., Brooklyn Law School, Magna Cum Laude

B.A., Emory University

New Jersey

New York

Supreme Court of the United States

U.S. Court of Appeals for the Second Circuit

U.S. District Court for the Eastern District of New York

U.S. District Court for the Southern District of New York

Law Clerk, Magistrate Judge Gabriel W. Gorenstein, U.S. District Court for the Southern District of New York